Marketing Drugs by Marketing Sex–Cheerleader Sales Reps Mon, 28 Nov 2005 Readers, but not the medical community, may be shocked by a front page story in The New York Times that sheds light on yet another unseemly pharmaceutical industry strategy for pushing brand name drugs. The industry’s most effective drug…
AMA Serves Pharma Marketing Priority/ FDA To Add Warnings on ADHD drugs–Concerta, Ritalin, Strattera, Adderall Wed, 29 Jun 2005 The FDA is finally taking note of the fact that many drugs prescribed for the treatment of psychiatric problems are CAUSING serious psychiatric and cardiovascular problems in children and adolescents !…
Cong. to act on GAO Finding: Families Give Up Kids to Get Treatment Tue, 29 Apr 2003 A report by the General Accounting Office (GAO) confirms that draconian state policies are causing families to break up when parents across America are forced to give up custody of their children in…
Infomail 2005 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav Subscribe to the AHRP infomail list Dec 16: Drugs, Devices & Doctors – NYT Paul Krugman Dec 11: Scientific Fraud & Corruption on Both sides of Atlantic: Merck / Proctor & Gamble Dec 11: Gov Accountability…
FDA says it Screened Panelists for Conflicts of Interest Tue, 1 Mar 2005 Bloomberg News reports that the Center for Science in the Public Interest had identified not 10, but 27 panelists on FDA’s advisory panel who had financial ties to drug manufacturers. Last week The New York Times reported…
July 26, 2002 Cancer Trials: 60% to 70% of subjects are children – Wall Street Journal The Wall Street Journal reports that there is a shortage of people volunteering to test experimental cancer drugs. “Overall, only 3% to 4% of cancer patients participate in trials. Most of those participants are…
FDA Advisory Suicide Risk for Adults on Antidepressants / Advisory Committee Resistant to issue Warnings on ADHD drugs Fri, 1 Jul 2005 Under public and congressional pressure to disclose fully the hazardous effects of widely prescribed drugs, the FDA is beginning to acknowledge the long-denied evidence: psychotropic drugs may INDUCE…
FDA sends contradictory message re: addictive drugs prescribed for children – NIMH admits cognitive therapy as good as SSRIs Fri, 27 May 2005 Two government health care agencies sent conflicting mixed messages about th euse of psychotropic drugs for children: The National Instiute of Mental Health issued an announcement acknowledging…
Lies & Broken Promises_Drug firm Websites Fail to Disclose Test Data Sun, 9 Jan 2005 One year after PhRMA’s publicized proclamation of its “commitment to transparency” The Boston Globe reviewed pharmaceutical company websites searching for disclosure of clinical trial data. The Globe found that this voluntary approach failed miserably: “Last…
Broken Brains or Flawed Studies? Thu, 24 Jul 2003 Broken Brains or Flawed Studies? A critical review of ADHD imaging studies by Jonathan Leo, Ph.D and David Cohen, Ph.D methodically demonstrates how scientifically flawed methodology undermines the integrity and claimed findings of over 30 imaging studies that are the basis…
FDA New Drug Safety Website – ADHD A Huge Profit-Engine for amphetamine-like drugs – The Street Sun, 22 May 2005 “After 25 years and 35 studies, there is not a single straightforward experiment comparing typical unmedicated children with an ADHD diagnosis to typical controls.” But science is not what the…
UK: ADHD advice secretly paid for by drugs companies Sun, 09 Oct 2005 The phenomenal marketing of ADHD in the US is credited mainly to the combined effort of CHADD, a family “advocacy” group and manufacturers of drugs prescribed for ADHD which fund CHADD. They are: Novartis (Ritalin), Shire (Adderral),…
